{
    "2021-09-29": [
        [
            {
                "time": "2021-ESMO",
                "original_text": "掘金创新药 | 2021ESMO年会盘点：君实生物PD-1治疗晚期食管癌生存期突破17个月 恒瑞医药新药初显抗癌潜力",
                "features": {
                    "keywords": [
                        "君实生物",
                        "PD-1",
                        "恒瑞医药",
                        "ESMO",
                        "晚期食管癌",
                        "抗癌潜力"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "拉闸限电后",
                "original_text": "拉闸限电之后，药企得注意这件事",
                "features": {
                    "keywords": [
                        "拉闸限电",
                        "药企"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "流感疫苗集中接种季",
                "original_text": "人民金融·创新药指数涨0.98% | 流感疫苗迎来集中接种季，三款重磅新药步入三期临床",
                "features": {
                    "keywords": [
                        "创新药指数",
                        "流感疫苗",
                        "三期临床"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "普瑞巴林缓释片获批",
                "original_text": "恒瑞医药(600276.SH)：普瑞巴林缓释片获得药品注册证书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "普瑞巴林缓释片",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "吸入用七氟烷获批",
                "original_text": "恒瑞医药(600276.SH)：吸入用七氟烷获得药品注册证书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "吸入用七氟烷",
                        "药品注册证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "仿制药一致性评价通过",
                "original_text": "恒瑞医药：注射用环磷酰胺药品通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "环磷酰胺",
                        "仿制药一致性评价"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "关节国采落地",
                "original_text": "医药健康行业周报(第三十七周)：关节国采落地 利空充分释放",
                "features": {
                    "keywords": [
                        "关节国采",
                        "利空释放"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "国内医药研发加速",
                "original_text": "国内医药研发“内循环”加速，重新定义Bigpharma的时刻到了",
                "features": {
                    "keywords": [
                        "医药研发",
                        "内循环",
                        "Bigpharma"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "艾瑞妥新适应症获批",
                "original_text": "恒瑞医药艾瑞妥新适应症获批",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "艾瑞妥",
                        "新适应症"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "两融余额减少",
                "original_text": "A股融资融券日报：两融余额减少32.66亿元（9月28日）",
                "features": {
                    "keywords": [
                        "两融余额",
                        "减少"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "资本市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "两项临床试验获批",
                "original_text": "恒瑞医药两项临床试验获批 分别用于治疗食管鳞癌、结直肠癌",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "临床试验",
                        "食管鳞癌",
                        "结直肠癌"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "A股成交额萎缩",
                "original_text": "A股成交额萎缩3000亿，原因在这？节前下跌节后上涨概率更大",
                "features": {
                    "keywords": [
                        "A股",
                        "成交额",
                        "萎缩",
                        "节前下跌",
                        "节后上涨"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "资本市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "资金流入民族品牌指数成分股",
                "original_text": "资金持续流入民族品牌指数成分股，机构看好投资价值",
                "features": {
                    "keywords": [
                        "民族品牌指数",
                        "资金流入",
                        "投资价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "资本市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "药企加速创新升级",
                "original_text": "药企加速创新升级，持续研发能力受关注",
                "features": {
                    "keywords": [
                        "药企",
                        "创新升级",
                        "研发能力"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}